Table 3.
Patient demographics
| Characteristics | Number of patients responding | n (%) or mean (SD) |
|---|---|---|
| Age, years [mean (SD)] | 20 | 45 (14.2) |
| Sex, n (%) | 20 | |
| Male | – | 9 (45) |
| Female | – | 11 (55) |
| Race, n (%) | 20 | |
| White | – | 18 (90) |
| Black or African-American | – | 1 (5) |
| Two or more races | – | 1 (5) |
| Duration of psoriasis, years [mean (SD)] | 19 | 18 (14) |
| Duration of genital psoriasis, years [mean (SD)] | 20 | 7.5 (9.7) |
| BSA score, mean (SD) | 15 | 10.4 (12.7) |
| Self-reported general health within past week, n (%) | 20 | – |
| Excellent | – | 2 (10) |
| Very good | – | 4 (20) |
| Good | – | 11 (55) |
| Fair | – | 3 (15) |
| Poor | – | 0 |
| Self-reported severity of overall psoriasis symptoms (worst over past 3 months), n (%) | 20 | – |
| 0 (clear) | – | 0 |
| 1 | – | 1 (5) |
| 2 | – | 1 (5) |
| 3 | – | 5 (25) |
| 4 | – | 5 (25) |
| 5 (severe) | – | 8 (40) |
| Self-reported severity of genital psoriasis symptoms (worst over past 3 months), n (%)a | 20 | – |
| 0 (clear) | – | 0 |
| 1 | – | 0 |
| 2 | 1 (5) | |
| 3 | – | 5 (25) |
| 4 | 8 (40) | |
| 5 (severe) | – | 6 (30) |
| Sexual activity status, n (%) | 20 | – |
| Not active | – | 9 (45) |
| Active | – | 9 (45) |
| Not askedb | – | 2 (10) |
| Currently receiving treatment for overall psoriasis, n (%) | 20 | 14 (70) |
BSA body surface area
aAll participants met eligibility criteria (Patient Global Assessment ≥ 4, 6-point scale from 0 to 5) at time of screening; the table reflects responses at the time of the interview
bThe question was not asked because of conversation flow, auditory cues, and subject’s apparent lack of comfort with sensitive topics per interviewer judgment